Remove news supplier-news
article thumbnail

STAT+: Cancer drug shortages widen disparities between big systems and small

STAT

The news crept under the radar until a few months later, Rice said, the drug was seemingly nowhere to be found. We went to put in our chemotherapy order, and our supplier said, ‘We don’t have any.’ “It came without warning. ’ It was like overnight.

article thumbnail

STAT+: Pharmalittle: South Africa ‘bullied’ into one-sided Covid vaccine deals; Astellas drops Medicare price-negotiation suit

STAT

Here’s some news. … South Africa was “bullied” into one-sided deals with Covid-19 vaccine suppliers, STAT reports. My coffee this morning is neither helium-blasted nor deep-fried, but it’s good to know the spirit of innovation is as alive and well in the world of beans as it is in Beantown.

Vaccines 201
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: Pharmalittle: Big PBM keeps AbbVie’s Humira on formulary; Lilly CEO says fake tweet means there’s more to do on insulin costs

STAT

… UnitedHealth Group’s pharmacy benefits manager, OptumRx, will keep AbbVie’s Humira alongside up to three biosimilar medicines next year, Bloomberg News writes. in 2023, giving prescription drug plans a chance to pit different suppliers against one another for discounts.

article thumbnail

Counterfeit diabetes pens identified in EU and UK

European Pharmaceutical Review

Ozempic: supply and falsification issues News of the falsified diabetes pen arrived as there has been heightened demand for the medicine. News of the falsified diabetes pen arrived as there has been heightened demand for the medicine. This has resulted in a supply shortage, EMA highlighted.

article thumbnail

Expert Guide on How BFSI Firms Can Accelerate Their ESG Programs

Pharma and Life Sciences Blog

Expert Guide on How BFSI Firms Can Accelerate Their ESG Programs annmarie@AZglo… Mon, 08/21/2023 - 22:57 The good news is that the banking, financial services and insurance (BFSI) sector, a key driver of global economic growth, can wield its powerful influence to drive sustainable societal change.

52
article thumbnail

Pharma unite to secure renewable energy in key manufacturing markets

European Pharmaceutical Review

Earlier in 2023, Task Force members launched joint, minimum environmental targets for suppliers. million tonnes of CO 2 per year across over 100 of the members’ largest pharmaceutical suppliers alone. This requested that organisations set science-based targets beyond carbon emissions reductions, SMI continued.

article thumbnail

Cosmo Entered into a License Agreement with Hyundai Pharm for Winlevi in Korea

PharmaShots

Shots: Cassiopea will receive an up front & is also eligible to receive regulatory and sales milestones along with royalties on net sales Hyundai Pharm to get an exclusive right to register and commercialize Winlevi in the Republic of Korea while Cosmo will be the exclusive supplier of the product.

40